Literature DB >> 848924

Microdilution transfer plate technique for determining in vitro synergy of antimicrobial agents.

P F Dougherty, D W Yotter, T R Matthews.   

Abstract

A microdilution transfer plate technique for determining in vitro synergy of antimicrobial agents is described. Combinations of gentamicin-nalidixic acid against Proteus mirabilis and rifampin-amphotericin B against Candida albicans are used as examples to demonstrate the technique. Results correlate with published data obtained by conventional methods. The technique is effective for evaluating the in vitro effects of antimicrobial agent combinations against both bacteria and fungi. The technique enables one to produce a checkerboard gradient in a fast, convenient, and reproducible way; results are easily visualized.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 848924      PMCID: PMC351957          DOI: 10.1128/AAC.11.2.225

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  14 in total

1.  Methods of testing combined antibiotic bactericidal action and the significance of the results.

Authors:  L P GARROD; P M WATERWORTH
Journal:  J Clin Pathol       Date:  1962-07       Impact factor: 3.411

2.  Antagonists of nucleic acid derivatives. VIII. Synergism in combinations of biochemically related antimetabolites.

Authors:  G B ELION; S SINGER; G H HITCHINGS
Journal:  J Biol Chem       Date:  1954-06       Impact factor: 5.157

3.  In vitro additive effect of polymxin B and rifampin against Serratia marcesen.

Authors:  W H Traub; I Kleber
Journal:  Antimicrob Agents Chemother       Date:  1975-06       Impact factor: 5.191

4.  Synergistic action of amphotericin B and rifampin on Candida albicans.

Authors:  W H Beggs; G A Sarosi; F A Andrews
Journal:  Am Rev Respir Dis       Date:  1974-11

5.  Bactericidal effect of combinations of nalidixic acid and various antibiotics on Enterobacteriaceae.

Authors:  J Michel; R Luboshitzky; T Sacks
Journal:  Antimicrob Agents Chemother       Date:  1973-09       Impact factor: 5.191

6.  Interaction of clindamycin and gentamicin in vitro.

Authors:  R J Fass; C A Rotilie; R B Prior
Journal:  Antimicrob Agents Chemother       Date:  1974-11       Impact factor: 5.191

7.  Combined activity of sulfamethoxazole, trimethoprim, and polymyxin B against gram-negative bacilli.

Authors:  J E Rosenblatt; P R Stewart
Journal:  Antimicrob Agents Chemother       Date:  1974-07       Impact factor: 5.191

8.  Effect of clindamycin on the in vitro activity of amikacin and gentamicin against gram-negative bacilli.

Authors:  S H Zinner; R B Provonchee; K S Elias; G Peter
Journal:  Antimicrob Agents Chemother       Date:  1976-04       Impact factor: 5.191

9.  Potentiation of rifampicin and 5-fluorocytosine as antifungal antibiotics by amphotericin B (yeast-membrane permeability-ribosomal RNA-eukaryotic cell-synergism).

Authors:  G Medoff; G S Kobayashi; C N Kwan; D Schlessinger; P Venkov
Journal:  Proc Natl Acad Sci U S A       Date:  1972-01       Impact factor: 11.205

10.  Comparative activity of tobramycin, amikacin, and gentamicin alone and with carbenicillin against Pseudomonas aeruginosa.

Authors:  R M Kluge; H C Standiford; B Tatem; V M Young; W H Greene; S C Schimpff; F M Calia; R B Hornick
Journal:  Antimicrob Agents Chemother       Date:  1974-10       Impact factor: 5.191

View more
  13 in total

1.  Potentiation of the activity of β-lactam antibiotics by farnesol and its derivatives.

Authors:  Choon Kim; Dusan Hesek; Mijoon Lee; Shahriar Mobashery
Journal:  Bioorg Med Chem Lett       Date:  2018-01-31       Impact factor: 2.823

2.  Serum bactericidal activity against Enterobacteriaceae producing broad-spectrum beta-lactamases in volunteers administered ofloxacin and cefotaxime, alone or combined.

Authors:  P Weber; Y Boussougant; R Farinotti; C Carbon
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-06       Impact factor: 3.267

3.  Adaptive resistance to the "last hope" antibiotics polymyxin B and colistin in Pseudomonas aeruginosa is mediated by the novel two-component regulatory system ParR-ParS.

Authors:  Lucía Fernández; W James Gooderham; Manjeet Bains; Joseph B McPhee; Irith Wiegand; Robert E W Hancock
Journal:  Antimicrob Agents Chemother       Date:  2010-06-14       Impact factor: 5.191

4.  Activity of sulbactam in combination with ceftriaxone in vitro and in experimental endocarditis caused by Escherichia coli producing SHV-2-like beta-lactamase.

Authors:  B Fantin; B Pangon; G Potel; F Caron; E Vallée; J M Vallois; J Mohler; A Buré; A Philippon; C Carbon
Journal:  Antimicrob Agents Chemother       Date:  1990-04       Impact factor: 5.191

5.  Interactions among amphotericin B, 5-fluorocytosine, ketoconazole, and miconazole against pathogenic fungi in vitro.

Authors:  F C Odds
Journal:  Antimicrob Agents Chemother       Date:  1982-11       Impact factor: 5.191

6.  Piperacillin, tazobactam, and gentamicin alone or combined in an endocarditis model of infection by a TEM-3-producing strain of Klebsiella pneumoniae or its susceptible variant.

Authors:  H Mentec; J M Vallois; A Bure; A Saleh-Mghir; F Jehl; C Carbon
Journal:  Antimicrob Agents Chemother       Date:  1992-09       Impact factor: 5.191

7.  Critical influence of resistance to streptogramin B-type antibiotics on activity of RP 59500 (quinupristin-dalfopristin) in experimental endocarditis due to Staphylococcus aureus.

Authors:  B Fantin; R Leclercq; Y Merlé; L Saint-Julien; C Veyrat; J Duval; C Carbon
Journal:  Antimicrob Agents Chemother       Date:  1995-02       Impact factor: 5.191

8.  Combined effect of amphotericin B and rifampin on Candida species.

Authors:  J E Edwards; J Morrison; D K Henderson; J Z Montgomerie
Journal:  Antimicrob Agents Chemother       Date:  1980-03       Impact factor: 5.191

9.  An in vitro synergistic interaction of combinations of Thymus glabrescens essential oil and its main constituents with chloramphenicol.

Authors:  Budimir S Ilić; Branislava D Kocić; Vojislav M Cirić; Olga G Ćvetković; Dragoljub L Miladinović
Journal:  ScientificWorldJournal       Date:  2014-01-28

10.  Low-level predation by lytic phage phiIPLA-RODI promotes biofilm formation and triggers the stringent response in Staphylococcus aureus.

Authors:  Lucía Fernández; Silvia González; Ana Belén Campelo; Beatriz Martínez; Ana Rodríguez; Pilar García
Journal:  Sci Rep       Date:  2017-01-19       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.